Oxygen Therapy Market

Oxygen Therapy Market Outlook and Growth Analysis Covering Market Size
during the Period 2017-2022
Global Oxygen Therapy Devices Market is anticipated to grow at a 5.90% CAGR from 2016
to 2021 and it is estimated that the global market was valued at USD 2.10 bn in 2016 and is
relied upon to achieve USD 2.97 bn by 2021. Technological advancements in respiratory
care services and a rise in the inclination of patients for convenient home oxygen therapy
device are key driving factors for oxygen therapy devices market.
View Full Report: http://marketdataforecast.com/market-reports/oxygentherapy-market-3688/
Different oxygen treatments are utilized to treat various respiratory infections due to their
supplementary and definitive role. Advantages of oxygen therapy also include increased
mental stamina, aversion of heart failure, and an enhanced breathing pattern. Global
oxygen market is driven by increasing application of oxygen supply. The administration and
supply of supplementary oxygen have turned into an indispensable part in the management
of numerous diseases. Oxygen therapy is applicable to numerous diseases, for example,
chronic obstructive pulmonary disease, asthma, respiratory distress syndrome, and
obstructive sleep apnea. Long-term oxygen treatments in patients suffering from chronic
lung disease are believed to enhance the length and the quality of life, in this way
contributing towards the swift development of the global oxygen therapy devices market.
Request for Sample: http://marketdataforecast.com/market-reports/oxygentherapy-market-3688/request-sample
The growth in different respiratory diseases is expected to be the driving force in the
development of the global oxygen therapy devices market in the coming years. Be that as it
may, poor compensation and constantly changing regulations related to oxygen therapy
devices are expected to hamper the growth of the global oxygen therapy devices market in
near future. Despite the fact that the global oxygen therapy devices market is expecting
hindrances due to a couple of restrictions, it will discover new development opportunities in
growing economies. Furthermore, government's initiative towards improving respiratory
care and an increase in government funding for the introduction of new medical devices are
predicted to profit the global oxygen therapy devices market.
Inquire Before Buying: http://marketdataforecast.com/market-reports/oxygentherapy-market-3688/inquire
The global market for oxygen therapy devices market is segmented into product type,
application and end user. On the basis of product, it is segmented into Oxygen Source
Equipment, Cylinders, Concentrators, Liquid Oxygen Devices, PAP, Oxygen Delivery
Device, Masks, Nasal Cannula, Venturi Mask, Non-Rebreather Mask, Bag Valve and
CPAP. Oxygen source equipment are expected to grow at 11% CAGR It is attributed to the

consolidation of this equipment in the extensive variety of uses as the first line of treatment.
On the basis of application, it is segmented into Chronic Obstructive Pulmonary Disease,
Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis,
Pneumonia. Chronic obstructive pulmonary disease holds the largest share of the
application segment and it is anticipated to grow lucratively at a CAGR of over 10.5% over
the next five years. This is due to increasing popularity of supplemental administration in
conjunction with first line treatments available for COPD. Moreover, this treatment includes
faster response rates, reliability and portability, and above all improves chances of survival.
On the basis of end use it is segmented into Home Healthcare and Hospitals. Home health
care dominates the end-use segment, owing to the rise in elderly population coupled with
increasing number of patients with low mobility and long-term care requirement in
conditions such as Alzheimer’s disease.
On the basis of geography, the global market is analyzed under various regions namely
North America, Europe, Asia-Pacific and Rest of the World. In 2016, the major share of
oxygen therapy market’s revenue was held by North America at staggering 40.0%. High
R&D investments and an increase in the number of product endorsements have been the
key growth drivers responsible for the North America’s largest share of the market. It is
followed by Europe in terms of revenue share owing to the presence of favorable
government initiatives for improving respiratory care, such as European Committee for
Hyperbaric Medicine (ECHM), involved in promoting awareness pertaining to the treatment.
The Asia-Pacific region is expected to offer a lucrative market in the future due to the
increasing elderly population who require home-based oxygen therapy. Furthermore, a rise
in healthcare expenditure in emerging economies such as China and India will further fuel
the market.
Respironics Inc. (a Philips company), Teleflex Incorporated, AirSep Corporation, DeVilbiss
Healthcare, ResMed Inc, Fisher & Paykel Healthcare Limited, Invacare Corporation are
some of the leading companies in the global oxygen therapy devices market.
About Us:
Market Data Forecast is a firm working in the area of market research and business
intelligence. With rich experience in research across various business domains, we
cater to the needs of both individual and corporate clients. Our analyst team comprises
expert professionals in market research, who with their collective knowledge and
sksillset dedicatedly serve clients from various industries and regions.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/pressreleases